SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-051929
Filing Date
2020-04-28
Accepted
2020-04-28 07:00:43
Documents
14
Period of Report
2020-04-27
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2017905d1_8k.htm   iXBRL 8-K 26467
2 EXHIBIT 99.1 tm2017905d1_ex99-1.htm EX-99.1 9016
6 GRAPHIC tm2017905d1_ex99-1img01.jpg GRAPHIC 9871
  Complete submission text file 0001104659-20-051929.txt   226572

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA egrx-20200427.xsd EX-101.SCH 3183
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE egrx-20200427_lab.xml EX-101.LAB 34591
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE egrx-20200427_pre.xml EX-101.PRE 22708
13 EXTRACTED XBRL INSTANCE DOCUMENT tm2017905d1_8k_htm.xml XML 3619
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Filer) CIK: 0000827871 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36306 | Film No.: 20822226
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences